empty

Pfizer

15 results found for: Pfizer

Running Covid vaccinations ‘hugely rewarding’ for pharmacist

A pharmacist running Covid-19 vaccinations in Brighton describes her involvement in the national immunisation programme as “hugely rewarding”.

PSNC: Let’s put a stop to GP flu jab competition

Simon Dukes says he is hopeful the Covid-19 pandemic will help put an end to competition between pharmacies and GP surgeries over flu jabs.

Pharmacists can alleviate Covid vaccine fears, BBC told

Pharmacists can alleviate people's fears about taking the Covid-19 vaccine, Thorrun Govind told the BBC. 

RPS: Government 'must involve pharmacies' in Covid jabs

RPS president Sandra Gidley has urged the government to employ pharmacies to roll out Covid-19 vaccines.

NHS in urgent talks with PSNC on Covid jabs

Pfizer/BioNTech says its vaccine candidate is more than 90 per cent effective in preventing Covid-19.

GSK & Pfizer close landmark OTC merger

GSK Consumer Healthcare and Pfizer Consumer Healthcare have announced the creation of a new joint venture as they reach the end of a lengthy merger process.   

UK government agrees fourth Covid vaccine deal

The two companies will supply the UK with 60 million doses of their protein adjuvant Covid-19 vaccine.

VIAGRA® CONNECT at the Counter

Build your confidence in advising customers with erection problems so you can help make a real difference to their lives 

VIAGRA CONNECT®: Key knowledge update

Update your knowledge of erection problems with key learning updates from recent research

Phenytoin 50mg Infatabs “unavailable,” warns PSNC

The PSNC has warned contractors that Pfizer's licensed phenytoin 50mg Infatabs is unavailable.

Talking Point shows real forward thinking

Best practice examples of a fully integrated community pharmacy network are showcased in the latest edition of ‘Talking Point’, a joint venture publication from Pharmacy Voice and Pfizer Healthy Partnerships.

Paying through the nose

Last month we heard the unedifying news that pharmaceutical companies were ripping off the NHS by charging inflated prices for generic medicines. The practice was first revealed in June 2016 by The Times, but it took a further six months for the Competition and Markets Authority (CMA) to announce its decision to fine Pfizer a record £84.2m and Flynn Pharma an additional £5.2m for charging “excessive and unfair prices” for phenytoin capsules. It seems incredible that generic medicines can be priced at levels many times higher than the cost of the original branded product.

The price is not always right

Victoria Goldman provides an update on the latest news from the generics market

Pfizer and Flynn fined £90m for phenytoin price hike

CMA imposes record fine on Pfizer and Flynn for charging excessive prices for phenytoin sodium capsules

Pfizer launches 'Kick it with help'

Pfizer enlists football professionals to promote expert stop smoking advice



This website is for healthcare professionals, people who work in pharmacy and pharmacy students. By clicking into any content, you confirm this describes you and that you agree to Independent Pharmacist's Terms of Use and Privacy Policy.

We use essential, performance, functional and advertising cookies to give you a better web experience. Find out how to manage these cookies here. We also use Interest Based Advertising Cookies to display relevant advertisements on this and other websites based on your viewing behaviour. By clicking "Accept" you agree to the use of these Cookies and our Cookie Policy.